Innovacell Overview

  • Status
  • Public

  • Employees
  • 50

Employees

  • Stock Symbol
  • 504A

Stock Symbol

  • Share Price
  • $3.15
  • (As of Thursday Closing)

Innovacell General Information

Description

Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Its activities include researching potential therapeutic candidates, developing formulations, and commercializing products in the markets. The company is working on the development and commercialization of the following three cell therapy pipelines targeting incontinence (fecal and urinary incontinence): ICEF15, ICEF16, and ICES13.

Contact Information

Website
innovacell.com
Formerly Known As
Innovacell Biotechnologie
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 5-11 Kamiosaki 3-chome
  • Shinagawa-ku
  • Tokyo, 141-0021
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TKS
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 5-11 Kamiosaki 3-chome
  • Shinagawa-ku
  • Tokyo, 141-0021
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innovacell Stock Performance

As of 12-Nov-2026, Innovacell’s stock price is $3.15. Its current market cap is $142M with 45.2M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.15 $3.20 $2.33 - $8.07 $142M 45.2M 93.1K -$0.64

Innovacell Financials Summary

As of 30-Jun-2026, Innovacell has a trailing 12-month revenue of $108K.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 55,455
Revenue 108 0 0 0
EBITDA (15,450) (12,926) (11,380) (11,449)
Net Income (21,122) (19,076) (15,797) (14,250)
Total Assets 75,695 32,556 18,051 17,046
Total Debt 13,431 33,218 26,487 25,072
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Innovacell Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Innovacell‘s full profile, request access.

Request a free trial

Innovacell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatmen
Drug Discovery
Tokyo, Japan
50 As of 2026

Zurich, Switzerland
 

Pittsburgh, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Innovacell Competitors (4)

One of Innovacell’s 4 competitors is MUVON Therapeutics, a Venture Capital-Backed company based in Zurich, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MUVON Therapeutics Venture Capital-Backed Zurich, Switzerland
Cook Myosite Corporation Pittsburgh, PA
Axonics Formerly VC-backed Irvine, CA
Coloplast Corporation Humlebaek, Denmark
To view Innovacell’s complete competitors history, request access »

Innovacell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Innovacell Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Innovacell‘s full profile, request access.

Request a free trial

Innovacell ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Innovacell’s complete esg history, request access »

Innovacell FAQs

  • Where is Innovacell headquartered?

    Innovacell is headquartered in Tokyo, Japan.

  • What is the size of Innovacell?

    Innovacell has 50 total employees.

  • What industry is Innovacell in?

    Innovacell’s primary industry is Drug Discovery.

  • Is Innovacell a private or public company?

    Innovacell is a Public company.

  • What is Innovacell’s stock symbol?

    The ticker symbol for Innovacell is 504A.

  • What is the current stock price of Innovacell?

    As of 12-Nov-2026 the stock price of Innovacell is $3.15.

  • What is the current market cap of Innovacell?

    The current market capitalization of Innovacell is $142M.

  • What is Innovacell’s current revenue?

    The trailing twelve month revenue for Innovacell is $108K.

  • Who are Innovacell’s competitors?

    MUVON Therapeutics, Cook Myosite, Axonics, and Coloplast are competitors of Innovacell.

  • What is Innovacell’s annual earnings per share (EPS)?

    Innovacell’s EPS for 12 months was -$0.64.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process